Chemotherapy Drugs Ovarian Cancer

Sunday, July 1, 2007

Randomized Phase III Trial of Gemcitabine Compared With Pegylated Liposomal Doxorubicin in Patients With Platinum-Resistant Ovarian Cancer

Posted by Khrissy Lupinacci at 7:12 AM No comments:
Newer Posts Older Posts Home
Subscribe to: Posts (Atom)

FDA-Electronic Orange Book

  • Approved Drug Products with Therapeutic Equivalence Evaluations

What Drug is Used to Treat a Disease?

  • FDA-What Drug is Used to Treat a Disease?

Clinical Trials: Questions and Answers

  • NCI- Clinical Trials: Questions and Answers

Ovarian Cancer Trial Results

  • NCI- Ovarian Cancer Trial Results

U. S. Food and Drug Administration • Center for Drug Evaluation and Research

  • What is the drug used for?

U.S. Food and Drug Administration • Center for Drug Evaluation and Research

  • Listing of Approved Oncology Drugs with Approved Indications

Cisplatin

  • cisplatin- NCI Drug Dictionary
  • Cisplatin- Wikipedia, the free encyclopedia
  • Cisplatin- MedlinePlus

Docetaxel-GENERIC NAME: BRAND NAME: Taxotere

  • Taxotere® (docetaxel)
  • Docetaxel-Medline Plus
  • Docetaxel-Wikipedia, the free encyclopedia

Blog Archive

  • ►  2008 (1)
    • ►  January (1)
  • ▼  2007 (8)
    • ▼  July (1)
      • Randomized Phase III Trial of Gemcitabine Compared...
    • ►  June (5)
    • ►  April (1)
    • ►  February (1)